Lower risk Drug recall · FDA · Published April 5, 2022

Eli Lilly Trulicity 0.75mg pens recalled due to temperature abuse risk

Eli Lilly recalls Trulicity injections that may have been exposed to improper temperatures. This could affect product stability and safety. Check your product details to see if you are affected.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0884-2022Drug Eli Lilly ›

Lower-risk recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

Take action

Contact the company

Recalling firmCardinal Health Inc.7000 Cardinal Pl · Dublin, OH 43017-1091

✎ GovInfoNow plain-language explainer

Eli Lilly has recalled Trulicity (dulaglutide) injections that may have been exposed to temperatures outside the labeled storage conditions. This could lead to product instability and potential safety risks for users. Read more at govinfonow.com/recall/34974-eli-lilly-trulicity-0-75mg-pens-recalled-due-to-temperature.

Source Summary by GovInfoNow · govinfonow.com/recall/34974-eli-lilly-trulicity-0-75mg-pens-recalled-due-to-temperature · Updated August 18, 2026 · FDA enforcement record: FDA #D-0884-2022

Cite this page

“Eli Lilly Trulicity 0.75mg pens recalled due to temperature abuse risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34974-eli-lilly-trulicity-0-75mg-pens-recalled-due-to-temperature. Based on FDA recall #D-0884-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0884-2022%22&limit=1).

Cardinal Health Inc. recalled Trulicity (dulaglutide) injection due to temperature abuse risks, the FDA announced on April 5, 2022. The product was distributed only in New Mexico.

How to tell if you have it

Brand: Eli Lilly
Product: Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens
NDC: 0002-1433-80
Lot #: D484557A
Expiration: 10/25/2023
Distribution: NM only

The hazard

The FDA stated the products were exposed to temperatures outside of the labeled storage conditions. The recall is classified as Class II.

Context

GovInfoNow's records show Cardinal Health Inc. has 11 other recalls on record since November 16, 2018. Recent similar recalls include Enoxaparin 30mg Syringes (August 5, 2025), RECOMBINATE Antihemophilic Factor (July 30, 2025), and Wegovy injection (April 9, 2025). Other recent recalls of similar products include UDENYCA Injection (January 16, 2026) and Gemcitabine Injection (June 10, 2026).

How to tell if you have this one

Check for the lot number D484557A and expiration date 10/25/2023 on the product label. The product is a 4 Single-Dose Pen of Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, prescription-only.

Brand
Eli Lilly
Category
Drug

FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

Status
Completed
Distribution
NM only

Recall number	Product, codes & lots	Class	NDC
D-0882-2022	Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59; Unknown	Class I	0002-7510-01, 0002-7510-17, 0002-7510-99, 0002-7533-01, 0002-8799-01, 0002-8799-59, 0002-8799-61, 0002-7516-01, 0002-7516-59, 0002-7516-99, 0002-7714-01, 0002-7714-59, 0002-7714-61, 0002-8213-01, 0002-8213-05, 0002-0800-01, 0002-7712-01, 0002-7712-27, 0002-7712-61, 0002-8208-01, 0002-8208-27
D-0883-2022	Trulicity (dulaglutide) injection, 1.5 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 00002-1434-80; Lot #: D482749A, Exp: 10/15/2023.	Class II	—
D-0884-2022	Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80; Lot #: D484557A, Exp: 10/25/2023.	Class II	0002-1433-01, 0002-1433-80, 0002-1433-61, 0002-1434-01, 0002-1434-80, 0002-1434-61, 0002-2236-01, 0002-2236-80, 0002-2236-61, 0002-3182-01, 0002-3182-80, 0002-3182-61

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for the lot number D484557A and expiration date 10/25/2023 on the product label.

Where it went and when

Where it was distributed

Distributed in New Mexico.

FDA distribution: “NM only” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New Mexico.

Recall timeline

FDA published this recall 50 days after the firm started it.

Apr 5, 2022Firm started the recall
May 19, 2022FDA classified it Class II
May 25, 2022Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Eli Lilly recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/34974-eli-lilly-trulicity-0-75mg-pens-recalled-due-to-temperature">Eli Lilly Trulicity 0.75mg pens recalled due to temperature abuse risk (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0884-2022 (April 5, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0884-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.